Search Results - "Magi, A"

The moderating role of mental health on the association between gaming time and gaming disorder symtoms by Koncz, P., Demetrovics, Z., Paksi, B., Magi, A., Eisinger, A., Király, O.

“…Introduction Video games are among the most popular leisure time activities. While majority of gamers play in a healthy manner, a minority shows gaming…”
Get full text

A new hybrid approach for MHC genotyping: high-throughput NGS and long read MinION nanopore sequencing, with application to the non-model vertebrate Alpine chamois (Rupicapra rupicapra) by Fuselli, S, Baptista, R P, Panziera, A, Magi, A, Guglielmi, S, Tonin, R, Benazzo, A, Bauzer, L G, Mazzoni, C J, Bertorelle, G

“…The major histocompatibility complex (MHC) acts as an interface between the immune system and infectious diseases. Accurate characterization and genotyping of…”
Get full text

Genome-wide identification of actionable copy number alterations from targeted sequencing panels with Excavator2 by Mazzarella, L., D'aurizio, R., Frige, G., Guida, A., Belloni, E., Marino, E., Bernard, L., Pelicci, P., Magi, A.

Get full text

Precision Trial Designer: A computational tool to assist in the design of genomics-driven trials in oncology by Mazzarella, L., Melloni, G., Guida, A., Curigliano, G., Botteri, E., Esposito, A., Kamal, M., Le Tourneau, C., Magi, A., Riva, L., Pelicci, P.

Get full text

RNA sequencing reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy by Mini, E, D’ Aurizio, R, Perrone, G, Magi, A, Lapucci, A, Tassi, R, Napoli, C, Picariello, L, Landini, I, Nobili, S

Get full text

Genetic analysis of 56 polymorphisms in 17 genes involved in methionine metabolism in patients with abdominal aortic aneurysm by Giusti, B, Saracini, C, Bolli, P, Magi, A, Sestini, I, Sticchi, E, Pratesi, G, Pulli, R, Pratesi, C, Abbate, R

“…Previous studies suggested an association between abdominal aortic aneurysm (AAA) and hyperhomocysteinaemia, a complex trait determined by genetic and…”
Get more information

Homocysteine status in former top-level male athletes: possible effect of physical activity and physical fitness by Unt, E., Zilmer, K., Mägi, A., Kullisaar, T., Kairane, C., Zilmer, M.

“…The importance of elevated homocysteine (Hcy) as a risk marker for cardiovascular disease is continously under debate. Lifestyle factors may increase the total…”
Get full text

Gene Expression Profiling of Peripheral Blood in Patients with Abdominal Aortic Aneurysm by Giusti, B, Rossi, L, Lapini, I, Magi, A, Pratesi, G, Lavitrano, M, Biasi, G.M, Pulli, R, Pratesi, C, Abbate, R

“…Abstract Object Abdominal aortic aneurysm (AAA) pathogenesis remains poorly understood. This study investigated the gene expression profile of peripheral blood…”
Get full text

Moment estimation in discrete shifting level model applied to fast array-CGH segmentation by Gandolfi, A., Benelli, M., Magi, A., Chiti, S.

“…We develop a mathematical theory needed for moment estimation of the parameters in a general shifting level process (SLP) treating, in particular, the finite…”
Get full text

Filaggrin mutations in relation to skin barrier and atopic dermatitis in early infancy by Hoyer, A., Rehbinder, E.M., Färdig, M., Asad, S., Lødrup Carlsen, K.C., Endre, K.M.A., Granum, B., Haugen, G., Hedlin, G., Monceyron Jonassen, C., Katayama, S., Konradsen, J.R., Landrø, L., LeBlanc, M., Olsson Mägi, C.A., Rudi, K., Skjerven, H.O., Staff, A.C., Vettukattil, R., Bradley, M., Nordlund, B., Söderhäll, C.

“…Summary Background Loss‐of‐function mutations in the skin barrier gene filaggrin (FLG) increase the risk of atopic dermatitis (AD), but their role in skin…”
Get full text

Carotid Artery Disease: Novel Pathophysiological Mechanisms Identified by Gene-expression Profiling of Peripheral Blood by Rossi, L, Lapini, I, Magi, A, Pratesi, G, Lavitrano, M, Biasi, G.M, Pulli, R, Pratesi, C, Abbate, R, Giusti, B

“…Abstract Object The pathogenesis of carotid artery stenosis (CAS) as well as the mechanisms underlying the different localisation of the atherosclerotic…”
Get full text

[104] DIFFERENTIAL GENE EXPRESSION PROFILES OF CAROTID ARTERY STENOSIS BIOPSIES OF HCV+ AND HCV PATIENTS SUGGEST PECULIAR MOLECULAR MECHANISMS IN THE PATHOGENESIS OF THE DISEASE by Rossi, L, Lapini, I, Magi, A, Boddi, M, Zignego, A.L, Pratesi, G, Pulli, R, Pratesi, C, Abbate, R, Giusti, B

Get full text

55 ISCHEMIC STROKE IN YOUNG ADULTS: GENETIC ANALYSIS OF 60 POLYMORPHISMS IN 17 GENES INVOLVED IN METHIONINE METABOLISM by Giusti, B, Saracini, C, Bolli, P, Magi, A, Rubattu, S, Martinelli, I, Peyvandi, F, Mannucci, P.M, Abbate, R

Get full text

3322 Complete lymph node dissection for Stage III malignant melanoma: Reducing morbidity by Teras, J, Teras, M, Mägi, A, Pata, P, Teras, R.M

Get full text

Atherogenic inflammatory and oxidative stress markers in relation to overweight values in male former athletes by PIHL, E, ZILMER, K, KULLISAAR, T, KAIRANE, C, MÄGI, A, ZILMER, M

“…To evaluate inflammation- and oxidative stress-related (OxS) background in former athletes in relation to overweight and abdominal obesity status…”
Get full text

111 GENETIC ANALYSIS OF POLYMORPHISMS IN GENES INVOLVED IN REMODELLING OF THE EXTRACELLULAR MATRIX AND SUSCEPTIBILITY TO ABDOMINAL AORTIC ANEURYSM by Saracini, C, Bolli, P, Magi, A, Sestini, I, Sticchi, E, Cellai, A.P, Pratesi, G, Pulli, R, Pratesi, C, Gensini, G.F, Abbate, R, Giusti, B

Get full text

106 CAROTID ARTERY DISEASE: IDENTIFICATION OF NOVEL PATHOPHYSIOLOGICAL MECHANISMS BY GENE EXPRESSION PROFILING OF PERIPHERAL BLOOD PERTURBATION by Rossi, L, Lapini, I, Magi, A, Pratesi, G, Maggini, N, Capalbo, A, Pucci, N, Pulli, R, Pratesi, C, Gensini, G.F, Abbate, R, Giusti, B

Get full text

61 GENE EXPRESSION PROFILING IN RAT LEFT VENTRICLE AFTER 10-WEEK MILD EXERCISE TRAINING by Lapini, I, Giusti, B, Rossi, L, Magi, A, Capalbo, A, Marini, M, Samaja, M, Esposito, F, Margonato, V, Boddi, M, Abbate, R, Veicsteinas, A

Get full text

Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma by Murumägi, Astrid, Ungureanu, Daniela, Khan, Suleiman, Arjama, Mariliina, Välimäki, Katja, Ianevski, Aleksandr, Ianevski, Philipp, Bergström, Rebecka, Dini, Alice, Kanerva, Anna, Koivisto-Korander, Riitta, Tapper, Johanna, Lassus, Heini, Loukovaara, Mikko, Mägi, Andrus, Hirasawa, Akira, Aoki, Daisuke, Pietiäinen, Vilja, Pellinen, Teijo, Bützow, Ralf, Aittokallio, Tero, Kallioniemi, Olli

“…Many efforts are underway to develop novel therapies against the aggressive high-grade serous ovarian cancers (HGSOCs), while our understanding of treatment…”
Get full text

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings by Kubicka, S., André, T., von Moos, R., Österlund, P., Reyes-Rivera, I., Müller, T., Arnold, D., Balcke, P., Benedicic, B., Eisterer, W., Fridrik, M., Samonigg, H., Arts, J., De Man, M., Janssens, J., Benczikova, B., Prausova, J., Vitek, P., Jensen, B.B., Keldsen, N., Østerlind, K., Borg, C., Breysacher, G., Chone, L., Dourthe, L.-M., Faroux, R., Illory, J.F., Lecomte, T., Legoux, J.-L., Levache, B., Lotz, J.-P., Mabro, M., Manfredi, S., Matysiak Budnik, T., Miglianico, L., Pezet, D., Porneuf, M., Tournigand, C., Viret, F., Ychou, M., Bangerter, M., Bertram, M.E., Bohnsteen, B., Cordes, H.-J., Eggert, J., Engel, E., Florschütz, A., Freier, W., Freund, M., Göhler, T., Hagen, V., Hebart, H.F., Heike, M., Höffkes, H.-G., Kettner, E., Kneba, M., Kojouharoff, G., Kretzschmar, A., Kröning, H., Lammert, F., Papke, J., Rädle, J., Ridwelski, K., Rudi, J., Schmalenberger, A., Schwarzer, A., Schwerdtfeger, M., Selbach, J., Staib, P., Stauch, M., Steffens, C.-C., Stübs, P., Tischendorf, J., Tummes, D., Von Wichert, G.P.L., Zomorodbaksch, B., Bloemendal, H.J., Guren, T., Soerbye, H., Fragoso, R., Mellidez, J.C., Darwish, T., Aparicio, J., Aranda, E., Camara, J.C., Donnay, O., Escudero, P., Gallego Plazas, J., Gonzalez Flores, E., Gravalos, C., Guardeno, R., Juárez, A., Massuti Sureda, B., Tobena, M., Toral, J.C., Valenti, V., Berglund, A., Fernebro, E., Hess-Umbricht, V., Popescu, R.

“…ML18147 evaluated continued bevacizumab with second-line chemotherapy for patients with metastatic colorectal cancer (mCRC) progressing after the standard…”
Get full text